A reduction of IKr/hERG currents due to either genetic defects or adverse drug effects can lead to hereditary or acquired long-QT syndrome in humans characterized by an increased risk for ventricular arrhythmias and sudden cardiac death (Marban, 2002). Here, KCNH2 is linked to acquired long QT syndrome.